CA Final · Integrated Business Solutions (Multidisciplinary Case Study with Strategic Management) · Advanced Financial Management
Case: Meridian Pharma Ltd, Hyderabad, has a UK subsidiary. In India, expected inflation is 6% p.a. and in the UK 2% p.a. Spot is Rs 105.00/GBP. Under purchasing power parity, what is the expected spot rate after 2 years (to the nearest paise)? Select the correct option.
Purchasing power parity says the rupee depreciates by the inflation differential. Expected spot after two years is 105 x (1.06/1.02)^2, which is about Rs 113.40 per pound. Simply adding the 4% differential or leaving the rate unchanged would be wrong.
- ARs 105.00
- BRs 113.40
- CRs 109.20
- DRs 113.38Correct
Explanation
Expected rate = 105 x (1.06/1.02)^2. 1.06/1.02 = 1.039216; squared = 1.079970. 105 x 1.079970 = 113.397, i.e. about Rs 113.40. Using the compounding check 105 x 1.1236 = 117.98 /1.0404 = 113.40. So the closest correct figure is Rs 113.40.
Did you get it right without looking?
One question tells you little. A timed set on Advanced Financial Management shows your real accuracy, how long you take and where you lose marks.
More Advanced Financial Management questions
- Case: Godavari Steels Ltd has two mutually exclusive projects, both with a 10% cost of capital. Project P: outlay Rs 10 lakh, PV of inflows …
- Case: Sanvi Pharma Ltd is demerging its API division into a new company, with shares issued proportionately to Sanvi's shareholders. Which d…
- Case: Meera Foods Ltd (equity Rs 40 crore) is considering a leveraged buyout of a division funded 80% by debt. The division generates stable…
- Case: Kaveri Foods Ltd is considering acquiring Malabar Spices Ltd through a purchase of its business in which Malabar's shareholders keep n…
- Case: Aryan Textiles Ltd is being valued by an asset-based approach before acquisition by Bharat Weaves Ltd. Book value of net assets is ₹80…
- Case: Meridian Pharma Ltd compares two equity funds for its treasury surplus. Fund A returned 16% with a standard deviation of 12% and beta …